- By insider

CEO and President of Penumbra Inc (30-Year Financial, Insider Trades) Adam Elsesser (insider trades) sold 8,000 shares of PEN on 09/11/2020 at an average price of $200.73 a share. The total sale was $1.6 million.

• Warning! GuruFocus has detected 4 Warning Signs with PEN. Click here to check it out.

• PEN 15-Year Financial Data

• The intrinsic value of PEN

• Peter Lynch Chart of PEN

Penumbra Inc designs, develops, manufactures and markets medical devices. The products of the company address ischemic stroke, hemorrhagic stroke and vascular conditions that can be treated through thrombectomy and embolization procedures. Penumbra Inc has a market cap of $7.14 billion; its shares were traded at around $197.88 with a P/E ratio of 682.34 and P/S ratio of 13.58. Penumbra Inc had annual average EBITDA growth of 56.90% over the past five years. GuruFocus has detected 2 severe warning signs with Penumbra Inc. .

CEO Recent Trades:

• CEO and President Adam Elsesser sold 8,000 shares of PEN stock on 09/11/2020 at the average price of $200.73. The price of the stock has decreased by 1.42% since.

Directors and Officers Recent Trades:

• President, International James Robert Pray sold 5,000 shares of PEN stock on 09/01/2020 at the average price of $212.74. The price of the stock has decreased by 6.99% since.

• President, International James Robert Pray sold 5,000 shares of PEN stock on 08/18/2020 at the average price of $235.11. The price of the stock has decreased by 15.84% since.

• EVP, Gen. Counsel & Secretary Johanna Roberts sold 2,000 shares of PEN stock on 08/17/2020 at the average price of $236.07. The price of the stock has decreased by 16.18% since.

For the complete insider trading history of PEN, click here

.This article first appeared on GuruFocus.